MEDP | NASDAQ
$598.12
-$26.06 | -4.18%
SIGNAL:
|2026-09-30
|F&G 53
|RSI 45.6
|2026-09-30
|F&G 53
|RSI 45.6
Company Overview:
Market Cap:
$16.69B
Trailing PE:
35x
FWD PE *:
32.5x
Payout Ratio (TTM):
—
52-Week Range:
$373.00 - $677.90
* Forward PE is based on street estimates.
7.7 Year MEDP Performance Metrics:
Total Return (with DRIP):
829% (33.57% CAGR)
Total Return (no DRIP):
829% (33.57% CAGR)
Share Price:
829% (33.57% CAGR)
Yield on Cost (with DRIP):
—
Total Invested:
$10,000
Total Value (with DRIP):
$92,876
Total Return $ (with DRIP):
$82,876
MEDP Total Return
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MEDP Price Chart
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
Unlock All Reports & Research Dividend Stocks like a BOSS!
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
MEDP Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
MEDP Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%
MEDP EPS CAGR:1Y: 37.10%2Y: 24.32%5Y: 32.01%10Y: 41.72%
MEDP Net Income CAGR:1Y: 34.46%2Y: 17.20%5Y: 24.98%10Y: 37.67%
MEDP EBITDA CAGR:1Y: 1.73%2Y: 9.12%5Y: 22.93%10Y: 16.70%
MEDP Free Cash Flow CAGR:1Y: -3.03%2Y: 15.50%5Y: 19.47%10Y: 39.29%
MEDP Free Cash Flow / Share CAGR:1Y: 1.02%2Y: 20.84%5Y: 25.27%10Y: 44.06%
MEDP Operating Income CAGR:1Y: 16.22%2Y: 18.17%5Y: 28.17%10Y: 26.39%
MEDP Gross Profit CAGR:1Y: 12.01%2Y: 14.49%5Y: 21.99%10Y: 16.60%
MEDP Shares Outstanding CAGR:1Y: -4.65%2Y: -5.32%5Y: -5.28%10Y: -3.16%
MEDP Share Buybacks CAGR:1Y: -45.51%2Y: 0.00%5Y: 39.46%10Y: 0.00%
MEDP Stock-Based Comp CAGR:1Y: -26.94%2Y: 10.08%5Y: 4.02%10Y: 2.90%
MEDP Expenses CAGR:1Y: 291.15%2Y: 36.30%5Y: 31.82%10Y: 26.73%
MEDP Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
MEDP Actual Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%
MEDP Actual EPS CAGR:1Y: 37.10%2Y: 24.32%5Y: 32.01%10Y: 41.72%
MEDP Actual Net Income CAGR:1Y: 34.46%2Y: 17.20%5Y: 24.98%10Y: 37.67%
MEDP Actual EBITDA CAGR:1Y: 1.73%2Y: 9.12%5Y: 22.93%10Y: 16.70%
Ratios, Profit Margins & Return on Capital:
MEDP Net Profit Margin CAGR:1Y: 14.71%2Y: 1.28%5Y: 3.64%10Y: 13.87%
MEDP Gross Profit Margin CAGR:1Y: -4.46%2Y: -1.07%5Y: 1.23%10Y: -3.56%
MEDP Price to Earnings CAGR:1Y: 23.71%2Y: -7.25%5Y: -5.00%10Y: -5.74%
MEDP Price To Sales Ratio CAGR:1Y: 38.16%2Y: -5.82%5Y: -1.43%10Y: 7.38%
MEDP Return on Capital Employed CAGR:1Y: -34.35%2Y: 44.28%5Y: 40.87%10Y: 30.33%
MEDP Return on Invested Capital CAGR:1Y: -22.38%2Y: 44.33%5Y: 39.51%10Y: 33.36%
Projected Future Returns & Dividends for MEDP
Based on past 7.7-year performance, here are MEDP growth metrics:
Share price CAGR of +33.57%
Dividend CAGR of +0%
Using MEDP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| MEDP (DRIP) | MEDP - No DRIP | |
|---|---|---|
| Current Price | $598.12 | $598.12 |
| Start Shares | 16.72 | 16.72 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 16.72 | 16.72 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $598.12 | $598.12 |
| Total Dividends | $0 | $0 |
| Final Value | $10,000 | $10,000 |
Estimated Future Value + Dividends - MEDP
NOTE: Above numbers are our estimate based on MEDP's Dividend and Price CAGR over past 7.7 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Company Info
Medpace Holdings, Inc. (MEDP) had its IPO on 2016-08-11, and is traded on NASDAQ stock exchange.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
MEDP website: https://www.medpace.com
Get Full Access to All Reports with DRIPCalc PRO
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Loading signals…
DCF Model — MEDP
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $598.12
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
